All Times EDT
Legend: CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
Activity Details
443
Wed, 8/10/2022,
10:30 AM -
11:15 AM
CC-Hall D
SPEED: Statistical Methods and Applications in Medical Research, Risk Analysis, and Marketing Part 2 — Contributed Poster Presentations
Biopharmaceutical Section , Section on Medical Devices and Diagnostics, Section on Statistics in Imaging, IMS, International Chinese Statistical Association, Section on Risk Analysis, Section on Statistics in Marketing
Chair(s): Michael Higgins, Kansas State University
01:
Near Real-Time Surveillance of COVID-19 Vaccine Safety in the U.S. Food and Drug Administration Biologics Effectiveness and Safety (BEST) Initiative Data Network
Mao Hu, Acumen LLC ; Patricia Lloyd, US Food and Drug Administration; Cindy Ke Zhou, US Food and Drug Administration; An-Chi Lo, Acumen LLC; Yoganand Chillarige, Acumen LLC; John Hornberger, Acumen LLC; Jeffrey Kelman, Centers for Medicare & Medicaid Services; Anne Marie Kline, Aetna; Cheryl N McMahill-Walraven, Aetna; Kandace L. Amend, Optum Epidemiology; John D Seeger, Optum Epidemiology; Daniel Beachler, HealthCore, Inc.; Alex Secora, IQVIA; Christian Reich, IQVIA; Azadeh Shoaibi, US Food and Drug Administration; Hui Lee Wong, US Food and Drug Administration; Steven Anderson, US Food and Drug Administration
02:
Dose Finding via Efficacy Biomarkers and Toxicity Endpoints in Immuno-Oncology Clinical Trials
Yiding Zhang, Sanofi ; Zhixing Xu, Sanofi; Ji Lin, Sanofi; Hui Quan, Sanofi
03:
Practical Implementation of Randomization in a Complex Site-Level Stepped-Wedge Cluster Pragmatic Randomized Trial
Wen Wan, Section of General Internal Medicine, University of Chicago ; Linda Rosul, Access community health network; Theodore Karrison, University of Chicago; Neda Laiteerapong, Section of General Internal Medicine, University of Chicago
04:
A Two-Stage Method to Minimize the Expected Sample Size of a Single-Arm Study Under the Alternative Hypothesis
Xiaobo Zhong, Bristol Myers Squibb ; Qian Li, Biostatistics and Strategic Consulting
05:
Improving Dose-Escalation Design with Historical and Concurrent Trial Data
Abhishek Kumar Dubey, Bristol Myer Squibb ; Arun Kumar Kumar, Bristol Myer Squibb; Kaushal Kumar Mishra, Bristol Myer Squibb
06:
BGLAM: A Bayesian General Logistic Autoregressive Model for Correlated Binary Outcomes
Ahmad Hakeem Abdul Wahab, Janssen Pharmaceuticals ; Arman Sabbaghi, Purdue University; Maggie O'Haire, Purdue University
07:
Practical Guidance on Mixture Priors Specification in Oncology Dose Escalation Models
Frank Shen, Bristol Myers Squibb ; Yanping Chen, Bristol Myers Squibb; Rong Liu, BMS
08:
Overlap Weight-Based Adaptive Bayesian Commensurate Prior for Augmenting the Control Arm of a Randomized Controlled Trial
Yeonil Kim, Merck & Co., Inc. ; Erina Paul, Merck & Co., Inc.
09:
Power Analysis for Longitudinal Cluster Randomized Trials with Binary Outcomes
Jijia Wang, UT Southwestern Medical Center
10:
Association of COVID Vaccine Hesitancy and Vaccine Misinformation Using Google Trends Analytics Vaccine Hesitancy
Lan Gao, The University of Tennessee at Chattanooga
11:
Extending the Weighted Generalized Score Statistic for Comparison of Correlated Means
Aaron D. Jones, Duke University ; Andrzej S. Kosinski, Duke University
12:
Can Cutaneous Squamous Cell Carcinoma Be Properly Graded? Investigation of the Differentiation Grading Among Dermatopathologists
Yevgeniya Gokun, The Ohio State University ; Xueliang Pan, The Ohio State University; David Carr, The Ohio State University; Katie Shahwan, The Ohio State University; Jessica Nash, The Ohio State University
13:
Evaluation of Patient-Reported Outcomes Using Kappa Statistics
14:
Statistical Considerations When Evaluating Diagnostic Devices with Categorical Output
15:
Homogeneity Test for Ordinal ROC Regression and Application to Facial Recognition
Ty Nguyen, University of Central Florida ; Larry Tang, University of Central Florida
16:
Club Exco: Clustering Brain Extreme Communities from Multi-Channel EEG Data
Matheus Bartolo Guerrero, King Abdullah University of Science and Technology ; Raphael Huser, King Abdullah University of Science and Technology (KAUST); Hernando Ombao, King Abdullah University of Science and Technology
17:
Large-Scale Correlation Screening Under Dependence for Brain Functional Connectivity Inference
Hanâ LBATH, Univ. Grenoble Alpes, CNRS, Inria, Grenoble INP, LJK ; Alexander Petersen, Brigham Young University; Sophie ACHARD, Univ. Grenoble Alpes, CNRS, Inria, Grenoble INP, LJK
18:
Correcting Under-Reporting in Cyber Incidents
Seema Sangari, Kennesaw State University ; Eric Dallal, Verisk
19:
Outcome-Dependent Sampling on Posterior Estimates of Salesperson Rankings
Neil Mercer, Google LLC ; Frank Yoon, Google LLC; Ignacio Martinez, Google LLC
20:
A Framework for Measuring Influencer Marketing
Gary Cohen, Amazon.com ; Vanja Dukic, Amazon.com
